Group 1 - Tiananmen Square will be closed from September 1 to September 3 for special activities, with reopening scheduled for September 4 [1] - The Beijing Municipal Government announced the temporary closure to ensure the smooth and safe conduct of the events [1] - Visitors are advised to plan their trips accordingly and cooperate with the arrangements [1] Group 2 - The Palace Museum (Forbidden City) will also be temporarily closed from August 31 to September 4, resuming normal operations on September 5 [2][3] - The closure is in coordination with the activities in the Tiananmen area [3]

Core Viewpoint - Tianan (00028) reported a significant increase in its interim results for the six months ending June 30, 2025, with substantial growth in both revenue and profit attributable to shareholders [1] Financial Performance - Revenue reached HKD 8.67 billion, representing a year-on-year increase of 459.59% [1] - Profit attributable to shareholders amounted to HKD 2.345 billion, showing a remarkable year-on-year increase of 2904% [1] - Basic earnings per share were HKD 1.5994 [1] Revenue Drivers - The increase in profit attributable to shareholders was primarily due to the revenue recognized from the delivery of units in the residential project Tianan No. 1 Phase II (Zone C) in Shanghai, China, which was delivered to customers at the beginning of 2025 [1]

Core Insights - Tianan (00028) reported an interim unaudited performance for the six months ending June 30, 2025, with revenue of HKD 8.67 billion, representing a year-on-year increase of 459.59% [1] - Shareholders' profit attributable increased to HKD 2.345 billion, a significant year-on-year rise of 2904% [1] - Basic earnings per share reached HKD 1.5994, reflecting the company's strong financial performance [1] Revenue Growth - The substantial increase in revenue is primarily attributed to the recognition of income from the delivery of units in the residential project Tianan No. 1 Phase II (Zone C) in Shanghai, China, which was delivered to customers at the beginning of 2025 [1] Profitability - The dramatic rise in shareholders' profit is linked to the successful sales and delivery of the aforementioned residential units, indicating strong demand and effective project execution [1]

Core Insights - The company reported a revenue of HKD 8,670.2 million for the six months ending June 30, 2025, representing a 4.6 times increase compared to the same period last year [1] - The attributable profit to shareholders was HKD 2,344.8 million, a significant increase of 29 times from HKD 78.1 million in 2024 [1] - The increase in profit is primarily attributed to the revenue recognized from the delivery of units in the residential project Tianan 1 Phase II (Zone C) in Shanghai, China, which was delivered to customers at the beginning of 2025 [1]

Financial Performance - Revenue for the six months ended June 30, 2025, reached HKD 8,670,198, a significant increase from HKD 1,549,382 in the same period of 2024, representing a growth of approximately 460%[3] - Gross profit for the same period was HKD 4,929,137, compared to HKD 542,115 in 2024, indicating a substantial increase in profitability[3] - The net profit for the six months ended June 30, 2025, was HKD 2,355,991, a remarkable rise from HKD 134,154 in 2024, reflecting an increase of about 1,661%[4] - Earnings per share for the period was HKD 159.94, compared to HKD 5.32 in the previous year, showcasing a significant improvement in shareholder value[4] - Total comprehensive income for the six months was HKD 2,732,969, up from HKD 110,852 in 2024, marking a substantial increase[6] - The company reported a pre-tax profit of HKD 4,462,013,000 for the six months ended June 30, 2025, compared to HKD 232,010,000 for the same period in 2024, indicating a substantial increase[15] - Profit attributable to shareholders for the same period was HKD 2,344.8 million, a 29 times increase from HKD 78.1 million year-on-year[26] Assets and Liabilities - Non-current assets as of June 30, 2025, totaled HKD 34,868,860, compared to HKD 33,468,166 at the end of 2024, indicating growth in asset base[7] - Current assets decreased to HKD 21,216,019 from HKD 24,942,926 in 2024, reflecting a reduction in liquidity[7] - Total assets less current liabilities amounted to HKD 37,675,692,000 as of June 30, 2025, compared to HKD 35,315,216,000 as of December 31, 2024, indicating a growth of approximately 6.7%[8] - The company's equity attributable to shareholders increased to HKD 28,948,767,000 from HKD 26,387,005,000, reflecting a growth of about 9.7%[8] - The non-current liabilities totaled HKD 6,939,135,000 as of June 30, 2025, a slight decrease from HKD 7,151,734,000 as of December 31, 2024[8] Income and Expenses - The company recognized a significant tax expense of HKD 2,174.9 million for the six months ended June 30, 2025, compared to HKD 133.1 million in the previous year[18] - The cost of inventory recognized as an expense was HKD 3,149.1 million, significantly higher than HKD 531.5 million in the prior period[19] - Other income and gains for the six months ended June 30, 2025, totaled HKD 111,709,000, a decrease from HKD 120,949,000 in the same period of 2024[17] Financing and Investments - The company incurred financing costs of HKD 97,304, down from HKD 111,350 in the previous year, indicating improved cost management[3] - The financing costs for the period were HKD 97,304,000, which is a decrease compared to HKD 111,350,000 for the same period in 2024[15] - The group plans to secure reasonably priced bank loans to maintain cash flow for potential land acquisitions and expedite project development[30] - The group provided guarantees amounting to approximately HKD 3,402.0 million related to mortgage loans and development projects[34] Business Segments - The property development segment generated external sales of HKD 7,405,562,000, contributing a segment profit of HKD 4,417,593,000, while the health care segment reported a profit of HKD 45,130,000[15] - The group operates primarily in China and Hong Kong, focusing on four main business segments: property development, property investment, health care, and other operations[13] Market Conditions - The People's Bank of China lowered the one-year Loan Prime Rate (LPR) by 10 basis points from 3.10% to 3.00% and the five-year LPR by 10 basis points from 3.60% to 3.50% in 2025, which is expected to alleviate financial burdens in the real estate sector[41] - The central government and local governments have introduced measures to stabilize the real estate market, including lowering mortgage rates and reducing down payment requirements[41] Employee and Operational Metrics - The group employed 3,900 employees as of June 30, 2025, an increase from 3,646 employees as of December 31, 2024[40] - Total registered sales for the first half of 2025 amounted to 62,300 square meters, a decrease of 51% compared to 126,800 square meters in 2024[28] - Completed total gross floor area was approximately 135,600 square meters, down 20% from 170,500 square meters in 2024[28] - Rental income slightly decreased by 3% compared to the same period in 2024[28] Dividends and Shareholder Returns - The company did not declare an interim dividend for the six months ended June 30, 2025, compared to HKD 293.2 million declared in the previous year[22] - The board has decided not to declare an interim dividend for the six months ending June 30, 2025, maintaining a prudent approach to capital retention[42] Accounting and Compliance - The company has maintained consistent accounting policies in line with Hong Kong Financial Reporting Standards, ensuring comparability with previous financial statements[11] - The audit committee reviewed the group's accounting principles and internal controls for the six months ending June 30, 2025, relying on the external auditor's review[45] - The company did not repurchase, sell, or redeem any of its listed securities during the six months ending June 30, 2025[46]

1 成員 2 會議次數 委員會應按需要時舉行會議。 3 出席會議 4 委員會決議案 一項經委員會全體成員簽署的書面決議案，應視為有效及有作用，猶如該決議案是 在一次妥為召開及舉行的委員會會議上通過一樣，而有關決議案可由一式多份，每 份由一名或多於一名委員會成員簽署的文件組成。 - 1 - (「本公司」) 提名委員會職權範圍 6 提名政策及程序 董事會應根據本公司業務而具備適當所需技巧、經驗及多樣的觀點與角度，並應確 保各董事能按其角色及董事會職責向本公司投入足夠時間並作出貢獻。董事會中執 行董事與非執行董事(包括獨立非執行董事)的組合應該保持均衡，以使董事會上有 強大的獨立元素，能夠有效地作出獨立判斷。為確保董事會組成人員的變動不會帶 來不適當的干擾，本公司應設有正式、經審慎考慮並具透明度的董事甄選、委任及 重新委任程序，並設定有秩序的董事繼任計劃(如認為有需要)，包括定期檢討此類 計劃。委任新董事(作為新增董事或填補所出現的臨時空缺)或重新委任任何董事乃 經委員會推薦候選人後由董事會作出決定。 - 2 - (a) 至少每年檢討董事會的架構、人數、組成及成員多元化，考慮因素包括但不 限於性別、年齡、文化背景、 ...

Market Overview - The Shanghai Composite Index rose by 0.13% on August 21, with a total trading volume of 2.46 trillion yuan, marking the seventh consecutive trading day with volumes exceeding 2 trillion yuan [1] - Nearly 2,200 stocks increased in price, with 58 stocks hitting the daily limit [1] Sector Performance - The combustible ice concept surged over 3%, with ShenKai Co., Ltd. (002278) hitting the limit, and other stocks like QianNeng HengXin (300191) and XinJin Power (300157) rising over 5% [1] - The digital currency sector saw multiple stocks hitting the limit, including Sanwei Xinan and BeiXinYuan (300352) [1] - The agriculture, forestry, animal husbandry, and fishery sector also performed well, with Guotou Zhonglu (600962) hitting the limit and Honghui Fruits and Vegetables (603336) and Muyuan Foods (002714) rising over 5% [1] Historical Highs - A total of 38 stocks reached historical closing highs, with the electronics, automotive, and machinery equipment sectors showing significant concentration [2] - The average increase for stocks reaching historical highs was 3.82%, with notable performers including ChuangYitong (300991) and GuoMai Culture (301052) [2][3] Institutional Activity - On August 21, 10 stocks saw net purchases exceeding 10 million yuan from institutions, with ZhongDian XinLong (002298) leading at 1.09 billion yuan [5] - The most sold stock by institutions was HengBao Co., Ltd. (002104), with a net sell of 1.1 billion yuan [5] Northbound Capital - Northbound capital was active in 18 stocks, with JingBeiFang (002987) receiving the highest net purchase of 1.76 billion yuan [7] - Stocks like WoLong Electric Drive (600580) and Electronic City (600658) also saw significant net purchases [7] Company Announcements - Sinopec (600028) plans to distribute a cash dividend of 0.088 yuan per share, totaling 10.67 billion yuan, despite a 10.6% decline in revenue year-on-year [8] - Renhe Pharmaceutical (000650) announced that its ULook brain-machine interaction smart glasses are still in the sample stage and have not yet generated sales revenue [8] - Shanghai Jahwa (600315) reported a 4.75% increase in revenue for the first half of the year, with a net profit growth of 11.66% [9]

Core Viewpoint - China Petroleum & Chemical Corporation (Sinopec) reported a significant decline in revenue and net profit for the first half of 2025, attributed to external challenges such as falling international oil prices and low chemical market margins [1][2] Financial Performance - For the first half of 2025, Sinopec achieved operating revenue of RMB 1.41 trillion, a year-on-year decrease of 10.6% [1] - The net profit attributable to shareholders was RMB 21.483 billion, down 39.8% year-on-year [1] - The company maintained a cash dividend payout ratio of 49.7%, proposing a cash dividend of RMB 0.088 per share, totaling RMB 10.67 billion [1] Production and Operations - Sinopec's oil and gas equivalent production reached 262.81 million barrels, a 2.0% increase year-on-year [1] - Domestic crude oil production was 126.73 million barrels, while natural gas production was 736.28 billion cubic feet [1] - The company plans to produce 141 million barrels of crude oil and 714.5 billion cubic feet of natural gas in the second half of 2025 [2] Capital Expenditure - Sinopec announced a 5% reduction in its annual capital expenditure plan, with a focus on optimizing resource allocation [3] - Capital expenditures in the exploration and development sector will target projects in Jiyang and Taha, among others [3] Share Buyback Plan - The company plans to repurchase shares worth between RMB 500 million and RMB 1 billion, with a maximum buyback price of RMB 8.72 per share [4] - The expected number of shares to be repurchased ranges from approximately 57.34 million to 114.68 million, representing 0.05% to 0.09% of the total issued shares [4] Other Companies' Dividend Announcements - Other listed companies, including Dong'e Ejiao and Baichu Electronics, also announced significant interim dividend plans, with Dong'e Ejiao proposing a cash dividend of RMB 12.69 per 10 shares, totaling RMB 817 million, which is 117.01% of its net profit for the first half of 2025 [5] - Baichu Electronics plans to distribute RMB 6.66 per 10 shares, amounting to RMB 192 million, or 30.01% of its net profit [5] - Samsung Medical announced a cash dividend of RMB 4.85 per 10 shares, totaling approximately RMB 679 million, which is 55.20% of its net profit [5]

Core Viewpoint - Several listed companies, including Sinopec, announced significant dividend distributions amidst challenging market conditions, with Sinopec reporting a notable decline in revenue and profit for the first half of 2025 [1][3]. Financial Performance - Sinopec's revenue for the first half of 2025 was RMB 1.41 trillion, a decrease of 10.6% year-on-year [2]. - The net profit attributable to shareholders was RMB 21.48 billion, down 39.8% compared to the same period last year [2]. - The company's cash flow from operating activities was RMB 61.02 billion, an increase of 44.4% year-on-year [2]. Production and Operations - Sinopec's oil and gas equivalent production reached 262.81 million barrels, a year-on-year increase of 2.0% [2]. - The company processed 11.997 million tons of crude oil and produced 7.14 million tons of refined oil during the first half of 2025 [2]. Dividend Distribution - Sinopec plans to distribute a cash dividend of RMB 0.088 per share, totaling approximately RMB 10.67 billion, with a cash dividend payout ratio of 49.7% [3]. - Other companies, such as Dong'e Ejiao and Baichu Electronics, also announced their dividend plans, with Dong'e Ejiao's total cash dividend expected to be RMB 8.17 billion, exceeding its net profit for the period [6]. Capital Expenditure - Sinopec announced a 5% reduction in its annual capital expenditure plan, focusing on optimizing resource allocation and project implementation [4]. - The capital expenditure for exploration and development will primarily support oil and gas production capacity construction [4]. Share Buyback Plan - Sinopec intends to use between RMB 5 billion and RMB 10 billion for a share buyback program, with a maximum repurchase price of RMB 8.72 per share [5].

今夜，又有多家上市公司大手笔分红。 中国石化还公告，为维护公司价值及股东权益，公司拟使用不低于人民币5亿元、不超过人民币10亿元 的自有资金和回购专项贷款，通过上海证券交易所（简称"上交所"）系统以集中竞价交易方式回购公司 发行的人民币普通股（A股）股票，回购价格上限为人民币8.72元/股，未超过董事会通过本次回购股份 方案的决议前30个交易日公司股票交易均价的150%。据此测算，预计本次回购股份数量约为5733.94万 股—11467.89万股，约占公司于本公告日已发行总股本的0.05%—0.09%。本次回购股份的期限自董事会 批准方案之日起不超过3个月，回购的股份将全部注销并减少注册资本。 值得一提的是，东阿阿胶、柏楚电子、三星医疗等上市公司21日晚间也公布了中期分红预案。 扬农化工拟向全体股东每10股派发现金红利2.40元（含税）。截至2025年6月30日，公司总股本4.05亿 股，以此计算拟派发现金红利9729.57万元（含税），占公司上半年归属于上市公司股东净利润的比例 为12.07%。 同时，公司拟以股权登记日当日登记的总股本为基数，每股派发现金股利人民币0.088元（含税）。若 根据截至本公告日 ...